Published: Guidance, quality standards and advice
Showing 301 to 310 of 2489
| Title | Reference number | Published | Last updated |
|---|---|---|---|
| Rimegepant for treating migraine | TA919 | ||
| Tofacitinib for treating active ankylosing spondylitis | TA920 | ||
| Ruxolitinib for treating polycythaemia vera | TA921 | ||
| Daridorexant for treating long-term insomnia | TA922 | ||
| Glofitamab for treating relapsed or refractory diffuse large B-cell lymphoma after 2 or more systemic treatments | TA927 | ||
| Virtual ward platform technologies for acute respiratory infections: early value assessment | HTE13 | ||
| Thyroid disease: assessment and management | NG145 | ||
| Bimekizumab for treating axial spondyloarthritis | TA918 | ||
| Pegunigalsidase alfa for treating Fabry disease | TA915 | ||
| Bimekizumab for treating active psoriatic arthritis | TA916 |